Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial
作者： Manish R Patel , John Ellerton , Jeffrey R Infante , Manish Agrawal , Michael Gordon
DOI: 10.1016/S1470-2045(17)30900-2
关键词:
摘要: Background The approval of anti-programmed death ligand 1 (PD-L1) and anti-programmed death 1 agents has expanded treatment options for patients with locally advanced or …
elsevier.com
sci-hub.se 参考文章(36)
Benjamin Boyerinas, Caroline Jochems, Massimo Fantini, Christopher R. Heery, James L. Gulley, Kwong Yok Tsang, Jeffrey Schlom, Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells. Cancer immunology research. ,vol. 3, pp. 1148- 1157 ,(2015) , 10.1158/2326-6066.CIR-15-0059
J A McCaffrey, S Hilton, M Mazumdar, S Sadan, W K Kelly, H I Scher, D F Bajorin, Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma. Journal of Clinical Oncology. ,vol. 15, pp. 1853- 1857 ,(1997) , 10.1200/JCO.1997.15.5.1853
Donald Kaufman, Derek Raghavan, Michael Carducci, Ellis Glenn Levine, Barbara Murphy, Joseph Aisner, Timothy Kuzel, Steven Nicol, William Oh, Walter Stadler, Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer Journal of Clinical Oncology. ,vol. 18, pp. 1921- 1927 ,(2000) , 10.1200/JCO.2000.18.9.1921
Juro Nakanishi, Yoshihiro Wada, Koichiro Matsumoto, Miyuki Azuma, Ken Kikuchi, Shoichi Ueda, Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers. Cancer Immunology, Immunotherapy. ,vol. 56, pp. 1173- 1182 ,(2007) , 10.1007/S00262-006-0266-Z
Jacques Ferlay, Hai-Rim Shin, Freddie Bray, David Forman, Colin Mathers, Donald Maxwell Parkin, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. ,vol. 127, pp. 2893- 2917 ,(2010) , 10.1002/IJC.25516
Stephen A. Boorjian, Yuri Sheinin, Paul L. Crispen, Sara A. Farmer, Christine M. Lohse, Susan M. Kuntz, Bradley C. Leibovich, Eugene D. Kwon, Igor Frank, T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival. Clinical Cancer Research. ,vol. 14, pp. 4800- 4808 ,(2008) , 10.1158/1078-0432.CCR-08-0731
Matthew D. Galsky, Svetlana Mironov, Alexia Iasonos, Joseph Scattergood, Mary G. Boyle, Dean F. Bajorin, Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma. Investigational New Drugs. ,vol. 25, pp. 265- 270 ,(2007) , 10.1007/S10637-006-9020-9
David J. Vaughn, Sandy Srinivas, Walter M. Stadler, Roberto Pili, Daniel Petrylak, Cora N. Sternberg, David C. Smith, Sarah Ringuette, Edwin de Wit, Virginie Pautret, Claude George, Vinflunine in platinum-pretreated patients with locally advanced or metastatic urothelial carcinoma: results of a large phase 2 study. Cancer. ,vol. 115, pp. 4110- 4117 ,(2009) , 10.1002/CNCR.24460
D. J. Vaughn, Phase II Trial of Weekly Paclitaxel in Patients With Previously Treated Advanced Urothelial Cancer Journal of Clinical Oncology. ,vol. 20, pp. 937- 940 ,(2002) , 10.1200/JCO.20.4.937
C. N. Sternberg, P. H.M. de Mulder, J. H. Schornagel, C. Théodore, S. D. Fossa, A. T. van Oosterom, F. Witjes, M. Spina, C. J. van Groeningen, C. de Balincourt, L. Collette, Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924 Journal of Clinical Oncology. ,vol. 19, pp. 2638- 2646 ,(2001) , 10.1200/JCO.2001.19.10.2638